earnings
NASDAQ · GLMD
Galmed Pharmaceuticals Ltd.
Healthcare · Biotechnology
$3.92
Down-$0.04 (-1.02%)
Updated Sep 5, 2026, 12:04 AM
SID Score
5.7/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 5.64M
- P/E ratio
- -0.47
- Dividend yield
- 0.00%
- 52-week range
- $0.41 – $5.45
- Volume
- 12.13K
- Avg. volume
- 2.06M
Price performance
GLMD price history
1M range · 20 trading sessions · Daily adjusted prices
GLMD closed at $3.92 after 20 trading sessions, up 551.27% for the selected period.
- Last close
- $3.92
- Period change
- +551.27%
- Period low
- $0.56
- Period high
- $4.77
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 3, 2026 | $4.05 | $4.062 | $3.90 | $3.92 | 12.13K |
| Sep 2, 2026 | $3.97 | $4.223 | $3.94 | $4.119 | 15.62K |
| Sep 1, 2026 | $4.07 | $4.12 | $3.8176 | $3.925 | 24.18K |
| Aug 31, 2026 | $4.04 | $4.16 | $4.03 | $4.12 | 7.21K |
| Aug 28, 2026 | $4.16 | $4.26 | $3.9588 | $4.165 | 5.37K |
| Aug 27, 2026 | $4.29 | $4.38 | $4.16 | $4.3056 | 6.12K |
| Aug 26, 2026 | $4.28 | $4.40 | $4.22 | $4.33 | 4.58K |
| Aug 25, 2026 | $4.08 | $4.49 | $3.9601 | $4.3053 | 40.19K |
| Aug 24, 2026 | $4.11 | $4.1298 | $3.6792 | $4.05 | 48.29K |
| Aug 21, 2026 | $4.54 | $4.54 | $4.12 | $4.305 | 22.21K |
| Aug 20, 2026 | $4.56 | $4.80 | $4.22 | $4.56 | 107.78K |
| Aug 19, 2026 | $5.38 | $5.4501 | $4.10 | $4.77 | 231.14K |
| Aug 18, 2026 | $4.208 | $4.624 | $4.16 | $4.4816 | 36.91K |
| Aug 17, 2026 | $4.16 | $4.88 | $3.9992 | $4.1072 | 120.95K |
| Aug 14, 2026 | $4.156 | $4.248 | $4.08 | $4.1848 | 5.69K |
| Aug 13, 2026 | $4.328 | $4.5464 | $4.24 | $4.248 | 3.64K |
| Aug 12, 2026 | $0.5569 | $0.5816 | $0.53 | $0.56 | 117.09K |
| Aug 11, 2026 | $0.5701 | $0.575 | $0.5501 | $0.5569 | 29.52K |
| Aug 10, 2026 | $0.598 | $0.60 | $0.5805 | $0.5931 | 14.65K |
| Aug 7, 2026 | $0.5741 | $0.6019 | $0.5729 | $0.6019 | 21.98K |
Latest GLMD news
The latest Smart Investors Daily articles mentioning GLMD.
Stock researchCompany · Earnings
Loading stock research…